Income Statement

MYRIAD GENETICS INC

MYGN
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Jun 30, 2020 2020 FY Jun 30, 2019 2019 FY Jun 30, 2018 2018 FY Jun 30, 2017 2017 FY Jun 30, 2016 2016 FY Jun 30, 2015 2015 FY Jun 30, 2014 2014 FY Jun 30, 2013 2013 FY Jun 30, 2012 2012 FY Jun 30, 2011 2011 FY
Revenue
824.50 837.60 753.20 678.40 690.60 638.60 851.10 772.60 771.40 753.80 723.10 778.22 613.17 496.01 402.08
Cost of Revenue
247.90 252.20 236.20 202.00 185.70 157.50 168.20 148.70 145.20 132.80 132.80 96.14 64.38 51.45 45.64
Gross Profit
576.60 585.40 517.00 476.40 504.90 481.10 682.90 623.90 626.20 621.00 590.30 682.08 548.79 444.55 356.45
Operating Expenses
963.80 708.90 661.60 600.10 619.70 587.30 641.40 537.90 550.80 429.70 441.50 394.57 305.55 251.03 197.59
Research & Development
106.80 113.40 88.70 85.40 81.90 77.20 85.90 70.80 74.40 70.60 75.50 67.48 53.71 42.65 27.75
Selling, General & Administrative
280.80 284.10 572.90 514.70 537.80 510.10 555.50 467.10 476.40 359.10 366.00 327.10 251.84 208.38 169.84
Other Operating Expenses
- - - - - - - - - - - - - - -
Operating Income
-387.20 -123.50 -144.60 -123.70 -114.80 -106.20 41.50 86.00 75.40 191.30 148.80 287.50 243.24 193.53 158.86
Non-Operating Income
-7.90 0.00 -4.80 0.00 133.40 8.40 -7.60 -1.80 -6.50 2.10 0.70 3.42 9.97 8.99 -0.80
Interest Income
1.80 1.70 2.50 2.60 0.70 3.00 3.20 1.80 1.20 0.90 0.40 5.40 5.50 4.63 2.23
Interest Expense
- - 2.90 3.20 6.60 10.80 12.00 3.20 6.00 - - - - - -
Other Non-Op Income / Expense
0.80 1.10 -4.40 0.60 139.30 16.20 1.20 -0.40 -2.50 1.20 0.30 -1.97 5.27 - -
Income Before Tax
-395.10 -123.50 -262.20 -140.60 -57.10 -223.30 0.00 116.90 42.90 168.90 134.90 277.87 233.28 184.54 159.65
Income Tax Expense
-29.20 3.80 1.10 -28.60 -29.90 -23.80 -4.60 -14.20 21.10 43.60 54.70 101.64 86.14 72.39 58.94
Non-Controlling Interest
- - - 0.00 0.00 -0.10 -0.20 -0.20 -0.20 - - - - - -
Net Income
-365.90 -127.30 -263.30 -112.00 -27.20 -199.50 4.60 131.10 21.80 125.30 80.20 176.23 147.14 112.15 100.71
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Jun 30, 2020 2020 FY Jun 30, 2019 2019 FY Jun 30, 2018 2018 FY Jun 30, 2017 2017 FY Jun 30, 2016 2016 FY Jun 30, 2015 2015 FY Jun 30, 2014 2014 FY Jun 30, 2013 2013 FY Jun 30, 2012 2012 FY Jun 30, 2011 2011 FY
Depreciation & Amortization
- - - - - - - - - - - - - - -
EBITDA
-333.50 -62.30 -82.70 -71.00 -52.00 -34.20 114.50 140.40 123.70 218.00 173.80 301.32 252.13 202.59 166.07
Earnings Per Share (Basic)
-3.95 -1.41 -3.18 -1.39 -0.35 -2.69 0.06 1.92 0.32 1.79 1.12 2.33 1.82 1.33 1.12
Diluted EPS
-3.95 -1.41 -3.18 -1.39 -0.35 -2.69 0.06 1.85 0.32 1.71 1.08 2.25 1.77 1.30 1.10
Weighted Average Shares
92.60 90.60 82.80 80.60 78.00 74.30 73.50 69.40 68.30 70.00 71.30 75.73 80.95 84.61 89.79
Diluted Weighted Avg Shares
92.60 90.60 82.80 80.60 78.00 74.30 76.00 72.00 68.80 73.40 74.50 78.18 83.33 86.47 91.70
Comprehensive Income
-364.30 -124.40 -258.10 -115.80 -30.00 -199.40 3.30 132.60 25.80 122.80 74.70 175.13 146.88 111.84 100.72